These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 28946616)

  • 1. Characterization of Growth Hormone Resistance in Experimental and Ulcerative Colitis.
    Soendergaard C; Kvist PH; Thygesen P; Reslow M; Nielsen OH; Kopchick JJ; Holm TL
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28946616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth Hormone Resistance-Special Focus on Inflammatory Bowel Disease.
    Soendergaard C; Young JA; Kopchick JJ
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28486400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct mechanisms of induction of hepatic growth hormone resistance by endogenous IL-6, TNF-α, and IL-1β.
    Zhao Y; Xiao X; Frank SJ; Lin HY; Xia Y
    Am J Physiol Endocrinol Metab; 2014 Jul; 307(2):E186-98. PubMed ID: 24895283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture.
    Thissen JP; Verniers J
    Endocrinology; 1997 Mar; 138(3):1078-84. PubMed ID: 9048612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KFL2 participates in the development of ulcerative colitis through inhibiting inflammation via regulating cytokines.
    Wang ZL; Wang YD; Wang K; Li JA; Li L
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4941-4948. PubMed ID: 30070340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of serotonin reuptake transporter gene expression in healing colonic mucosa in presence of remaining low-grade inflammation in ulcerative colitis.
    Tada Y; Ishihara S; Kawashima K; Fukuba N; Sonoyama H; Kusunoki R; Oka A; Mishima Y; Oshima N; Moriyama I; Yuki T; Ishikawa N; Araki A; Harada Y; Maruyama R; Kinoshita Y
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1443-52. PubMed ID: 26676714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of Averrhoa bilimbi L. fruit extract on ulcerative colitis in wistar rats via regulation of inflammatory mediators and cytokines.
    Suluvoy JK; Sakthivel KM; Guruvayoorappan C; Berlin Grace VM
    Biomed Pharmacother; 2017 Jul; 91():1113-1121. PubMed ID: 28531922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrosis Mediators in the Colonic Mucosa of Acute and Healed Ulcerative Colitis.
    Gundersen MD; Goll R; Fenton CG; Anderssen E; Sørbye SW; Florholmen JR; Paulssen RH
    Clin Transl Gastroenterol; 2019 Oct; 10(10):e00082. PubMed ID: 31584460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo.
    Scheibe K; Backert I; Wirtz S; Hueber A; Schett G; Vieth M; Probst HC; Bopp T; Neurath MF; Neufert C
    Gut; 2017 May; 66(5):823-838. PubMed ID: 26783184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of interleukin 33 expression in colonic crypts - a potential marker for disease remission in ulcerative colitis.
    Gundersen MD; Goll R; Hol J; Olsen T; Rismo R; Sørbye SW; Sundnes O; Haraldsen G; Florholmen J
    Sci Rep; 2016 Oct; 6():35403. PubMed ID: 27748438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Effects of Anti-Inflammatory
    Cordeiro N; Freitas RHCN; Fraga CAM; Fernandes PD
    J Pharmacol Exp Ther; 2020 Sep; 374(3):420-427. PubMed ID: 32546529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between IGF-1 and body weight in inflammatory bowel diseases: Cellular and molecular mechanisms involved.
    Guijarro LG; Cano-Martínez D; Toledo-Lobo MV; Salinas PS; Chaparro M; Gómez-Lahoz AM; Zoullas S; Rodríguez-Torres R; Román ID; Monasor LS; Ruiz-Llorente L; Del Carmen Boyano-Adánez M; Guerra I; Iborra M; Cabriada JL; Bujanda L; Taxonera C; García-Sánchez V; Marín-Jiménez I; Acosta MB; Vera I; Martín-Arranz MD; Mesonero F; Sempere L; Gomollón F; Hinojosa J; Alvarez-Mon M; Gisbert JP; Ortega MA; Hernández-Breijo B; On Behalf Of The Predicrohn Study Group From Geteccu
    Biomed Pharmacother; 2021 Dec; 144():112239. PubMed ID: 34601192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-206 is involved in the pathogenesis of ulcerative colitis via regulation of adenosine A3 receptor.
    Wu W; He Y; Feng X; Ye S; Wang H; Tan W; Yu C; Hu J; Zheng R; Zhou Y
    Oncotarget; 2017 Jan; 8(1):705-721. PubMed ID: 27893428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis.
    Ishiguro Y
    J Gastroenterol; 1999 Feb; 34(1):66-74. PubMed ID: 10204613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-33 Signaling Protects from Murine Oxazolone Colitis by Supporting Intestinal Epithelial Function.
    Waddell A; Vallance JE; Moore PD; Hummel AT; Wu D; Shanmukhappa SK; Fei L; Washington MK; Minar P; Coburn LA; Nakae S; Wilson KT; Denson LA; Hogan SP; Rosen MJ
    Inflamm Bowel Dis; 2015 Dec; 21(12):2737-46. PubMed ID: 26313694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
    Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
    Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTGF-mediated ERK signaling pathway influences the inflammatory factors and intestinal flora in ulcerative colitis.
    Song ZM; Liu F; Chen YM; Liu YJ; Wang XD; Du SY
    Biomed Pharmacother; 2019 Mar; 111():1429-1437. PubMed ID: 30841458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of lipocalin-type-prostaglandin D synthase in ulcerative colitis and exacerbating role in murine colitis.
    Hokari R; Kurihara C; Nagata N; Aritake K; Okada Y; Watanabe C; Komoto S; Nakamura M; Kawaguchi A; Nagao S; Urade Y; Miura S
    Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G401-8. PubMed ID: 21163901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis.
    Rismo R; Olsen T; Cui G; Christiansen I; Florholmen J; Goll R
    Scand J Gastroenterol; 2012 May; 47(5):538-47. PubMed ID: 22486187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.